Comparing blood thinners for heart artery tear recovery
Part of Heart & circulation clinical trials.
This trial tests two different blood-thinner plans for people who have had a tear in a heart artery (spontaneous coronary artery dissection, or SCAD) and are being treated without surgery. The goal is to find out if one approach is safer and works better for healing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You recently had a heart attack or unstable angina (acute coronary syndrome).
- A heart catheterization showed a tear in a heart artery (SCAD).
- Your doctor plans to treat the tear without stents or surgery (conservative management).
- You are able to give informed consent and are willing to participate for the full study.
- If you are a woman who could become pregnant, you agree to use birth control during the study (until the 12-month follow-up).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two common heart medicines (beta-blockers and antiplatelets) to see which works better for people who have had a spontaneous coronary artery dissection (SCAD), a tear in a heart artery. It aims to prevent future heart problems.
This study tests whether a personalized score (OPT-CAD) can help decide the best time to stop or reduce blood-thinning medication in people who have had a heart attack and a stent placed. It aims to balance preventing future heart issues while lowering the risk of bleeding.
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
This study aims to improve how doctors monitor and guide treatment for people with heart disease who have had a stent placed. It focuses on finding the best ways to manage blood-thinning medications to reduce risks of bleeding and clotting.
This trial tests switching from a standard blood thinner (clopidogrel) to a lower dose of a stronger one (prasugrel) in people who have had a stent placed and are at high risk for both bleeding and heart problems. The goal is to see if the switch better prevents clots while keeping bleeding risks low.
This study compares two different blood-thinner treatment approaches in people who have recently had a stroke or mini-stroke caused by a tear in an artery in the neck. The goal is to find out which treatment is safer and more effective at preventing further strokes.
Hear when a new SCAD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.